Brief: Zynex Monitoring Solutions Announces First Enrollment In Blood Loss Detection Clinical Trial For Its CM-1600 Monitoring System
21/09/2022 14:17
Sept 21 (Reuters) - Zynex Inc ZYXI.O :
* ZYNEX MONITORING SOLUTIONS ANNOUNCES FIRST ENROLLMENT IN A
BLOOD
LOSS DETECTION CLINICAL TRIAL FOR ITS CM-1600 MONITORING SYSTEM
* ZYNEX INC - TRIAL IS EXPECTED TO INCLUDE UP TO 227
SUBJECTS AND
WILL COMPLETE ENROLLMENTS IN EARLY 2023
Source text for Eikon: ID:nPn8KfDx7a
Further company coverage: ZYXI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zynex
See all newsBrief: Court Confirms Zynex Plan Of Reorganization On March 19, 2026 - SEC Filing
Brief: Zynex Inc Says SEC Concluded Investigation Into Zynex, No Enforcement Action Planned
Brief: Zynex Inc Resolves Federal Investigation Into Business Practices
Brief: Zynex Secures $22.3 Million Dip Facility From Lenders And CEO
Brief: Zynex Financial Restructuring Puts Company On Path To Long-Term Success